Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp. -- Ignore unavailable to you. Want to Upgrade?

To: RockyBalboa who wrote (1308)	11/7/1998 10:40:00 PM
From: Ron	Read Replies (2) \| Respond to of 3576

Interesting NY Times Editorial this weekend: A Ban on Cells That Could Heal he breakthrough in growing human stem cells in the laboratory with private funding is not only a stunning achievement, it is a rebuke to Congress for banning Federal funding of this exciting research. Scientists are now poised to explore new therapies for dreaded diseases. Yet, thanks to a Congressional ban on Federal funding for most research on embryos, the Government may find it hard to accelerate a promising field or monitor its ethical issues. The research involves cultivating "human embryonic stem cells" before they have begun to differentiate into the specialized cells that form the individual parts of the body. It opens the way to grow heart cells for cardiac patients, brain tissue for Parkinson's patients, or bone marrow to treat leukemia and other cancers. Such treatments are years away. Scientists must first learn how to nudge the stem cells to develop into specific tissues and organs, and they must keep the transplanted cells from being rejected by a patient's immune system. Thus the first use of the cells will almost certainly be for research. Whether the Government can play a significant role is uncertain. At least one of the studies just reported would almost certainly have been barred from Federal funding by the Congressional ban on embryo research. This is a sad state given that the gains are potentially enormous and the ethical problems appear minimal. One research team used cells from fertilized eggs that would otherwise have been discarded after treating infertile couples, and the other used cells from already aborted fetuses. They literally created a major advance from cells that would otherwise have been wasted.